Vericiguat in heart failure: From scientific evidence to clinical practice.
Sign Up to like & getrecommendations! Published in 2022 at "Revista clinica espanola"
DOI: 10.1016/j.rceng.2021.12.006
Abstract: Despite currently available treatments, risk of death and hospitalizations in patients with heart failure with reduced ejection fraction (HFrEF) remains high. The pathophysiology of HFrEF includes neurohormonal activation characterized by stimulation of deleterious pathways (i.e.,… read more here.
Keywords: heart; failure scientific; vericiguat heart; scientific evidence ... See more keywords